This article is intended for primary care clinicians, infectious disease specialists, hospitalists, and other specialists who care for hospitalized patients.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity, Medscape Education Clinical Briefs has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins September 1, 2010. Term of approval is for 1 year from this date. Each issue is approved for .25 Prescribed credits. Credit may be claimed for 1 year from the date of this issue.
Note: Total credit is subject to change based on topic selection and article length.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
AAFP Accreditation Questions
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME Released: 4/18/2011
Valid for credit through: 4/18/2012, 11:59 PM EST
processing....
April 18, 2011 — Universal surveillance, contact precautions, hand hygiene, and institutional culture change are linked to reduced transmissions and infections of methicillin-resistant Staphylococcus aureus (MRSA) in a large Veterans Affairs (VA) healthcare system, according to the results of a study reported in the April 14 issue of The New England Journal of Medicine.
These results are similar to those found in a study, as previously reported by Medscape Medical News, that showed enhanced cleaning of intensive care units (ICUs) with disinfectant-saturated cloths, an educational campaign, and targeted feedback could decrease transmission of MRSA or vancomycin-resistant enterococci.
"MRSA Bundles" Effective
The current study indicates that "Health care–associated infections with ...MRSA have been an increasing concern in ...VA hospitals."
"A 'MRSA bundle' was implemented in 2007 in acute care VA hospitals nationwide in an effort to decrease health care–associated infections with MRSA," write Rajiv Jain, MD, from the Veterans Health Administration MRSA Program Office, Patient Care Services, VA Central Office, and the VA Pittsburgh Healthcare System in Pittsburgh, Pennsylvania.
"The bundle consisted of universal nasal surveillance for MRSA, contact precautions for patients colonized or infected with MRSA, hand hygiene, and a change in the institutional culture whereby infection control would become the responsibility of everyone who had contact with patients."
At each facility, staff entered aggregate data into a central database each month on adherence to surveillance practice, prevalence of MRSA colonization or infection, and healthcare-associated transmissions of and infections with MRSA. The investigators evaluated the effect of the MRSA bundle on healthcare-associated MRSA infections from October 2007, when the bundle was fully implemented, through June 2010.
During this period, there were 1,934,598 admissions to or transfers or discharges from ICUs (n = 365,139) and non-ICUs (n = 1,569,459) and 8,318,675 patient-days, including 1,312,840 ICU patient-days and 7,005,835 non-ICU patient-days. The percentage of patients who were screened at admission increased from 82% to 96%, and those screened at transfer or discharge increased from 72% to 93%. At the time of hospital admission, the mean prevalence of MRSA colonization or infection was 13.6 ± 3.7%.
Although rates of healthcare-associated MRSA infections in ICUs did not change in the 2 years preceding October 2007 (P = .50 for trend), there was a significant 62% decrease associated with implementation of the bundle, from 1.64 infections per 1000 patient-days in October 2007 to 0.62 per 1000 patient-days in June 2010 (P < .001 for trend). Rates of healthcare-associated MRSA infections in non-ICUs also decreased (by 45%) from 0.47 per 1000 patient-days to 0.26 per 1000 patient-days (P < .001 for trend).
"A program of universal surveillance, contact precautions, hand hygiene, and institutional culture change was associated with a decrease in health care–associated transmissions of and infections with MRSA in a large health care system," the study authors write.
Limitations of this study include lack of data to determine the extent to which each component of the bundle or concomitant infection–control initiatives may have contributed to the overall reduction in healthcare-associated infections.
"Although we did not make a formal cost–benefit assessment of the VA MRSA Prevention Initiative, others have reported that programs of active surveillance are cost-effective over a wide range of prevalence and transmission rates," the study authors conclude. "Expanding elements of the program to long-term and ambulatory care settings may be necessary to deal with reservoirs of MRSA throughout the health care system."
Opposing Study Findings
Another study, published in the same issue of The New England Journal of Medicine as the current study, reached nearly opposite conclusions. A 6-month intervention in 18 ICUs was ineffective in reducing the transmission of MRSA and vancomycin-resistant enterococci, but the use of barrier precautions by providers was less than what the intervention required.
In an accompanying editorial, Richard Platt, MD, from the Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School in Boston, Massachusetts, suggests that the divergent results of the 2 current studies might be attributed to different study designs.
"It is also possible that the benefits Jain et al. observed were due to factors other than the MRSA bundle," Dr. Platt writes. "The VA system had introduced guidelines addressing ventilator-associated pneumonia and central-line–associated bloodstream infections in the previous year. It also issued a guidance document on decolonization of MRSA-colonized patients approximately 6 months after full implementation of the MRSA bundle, at about the time the dramatic drop in infections occurred. Interrupted time-series analyses incorporating the MRSA bundle and these other interventions might help elucidate the effect of the bundle."
Comments by Dr. John Jernigan, coauthor and the CDC's director of Healthcare-Associated Infection Prevention Research and Evaluation, are available as a CDC Expert Video Commentary on Medscape.
The study authors have disclosed no relevant financial relationships. Disclosure forms provided by Dr. Platt are available with the full text of this article at The New England Journal of Medicine Web site.
N Engl J Med. 2011;364:1419-1430, 1464-1465. Abstract Extract
MRSA is one of the most common causes of ventilator-associated pneumonia, bloodstream infection associated with central venous catheters, and surgical-site infections. The VA system and the CDC in 2001 implemented an MRSA bundle that was shown to reduce MRSA-associated infection on surgical wards by 60% and 1 surgical ICU by 75%. Based on this pilot, a nationwide initiative was implemented by 2007 at all VA facilities admitting patients.
This is a report of the effect of the program on MRSA screening and infection rates at ICU and non-ICU facilities at VA facilities nationwide.